https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Drying non-halogenated materials is suggested.
2 hours @ 100 (38)
Moisture Range
(%)
Not required
https://www.avient.com/sites/default/files/2022-06/MEVOPUR Bio-based Solutions Application Bulletin_CN %281%29.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2024-09/Compensation Committee Charter July 2024.pdf
With the assistance of management and any outside advisers the Committee deems
appropriate (a) review and discuss with management the Company’s disclosures in the
CD&A, and, based on this review, make a recommendation as to whether to include it in the
Company’s annual report on Form 10-K and proxy statement relating to the Company’s
4
annual meeting of shareholders, and (b) prepare a Compensation Committee Report for
inclusion in the Company’s proxy statement or other applicable SEC filings.
https://www.avient.com/sites/default/files/2024-10/Compensation Committee Charter - Final.pdf
With the assistance of management and any outside advisers the Committee deems
appropriate (a) review and discuss with management the Company’s disclosures in the
CD&A, and, based on this review, make a recommendation as to whether to include it in the
Company’s annual report on Form 10-K and proxy statement relating to the Company’s
annual meeting of shareholders, and (b) prepare a Compensation Committee Report for
inclusion in the Company’s proxy statement or other applicable SEC filings.
4
Board Reports and Annual Evaluation
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2024-results
December 4
Attachment 4
https://www.avient.com/investor-center/news/polyone-announces-third-quarter-2016-results
Adjusted earnings per share increased 4% to
Attachment 4
https://www.avient.com/investor-center/news/polyone-announces-third-quarter-2019-results
3% below the third quarter of the prior year, as growth from acquisitions of 4% partially offset a 6% reduction in organic sales and a 1% reduction due to unfavorable foreign exchange.
Attachment 4
https://www.avient.com/investor-center/news/polyone-announces-full-year-and-fourth-quarter-2018-results
Revenue increased 4% (3% organic) to $834 million
Attachment 4
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations
Standard and customized grades offering 20-100% post-industrial recycled (PIR) content or grades formulated with 100% post-consumer recycled (PCR) nylon to support the circular economy